Sanctuary Wealth Management’s State Street SPDR Portfolio Developed World ex-US ETF SPDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$152K Hold
4,460
0.1% 50
2024
Q3
$168K Hold
4,460
0.12% 48
2024
Q2
$156K Buy
4,460
+416
+10% +$14.8K 0.12% 48
2024
Q1
$145K Hold
4,044
0.12% 52
2023
Q4
$138K Hold
4,044
0.13% 50
2023
Q3
$125K Hold
4,044
0.14% 44
2023
Q2
$132K Buy
+4,044
New +$132K 0.14% 41
2022
Q4
$120K Buy
+4,044
New +$116K 0.14% 37
2018
Q3
Sell
-71,455
Closed -$2.17M 23
2018
Q2
$2.17M Buy
71,455
+20,887
+41% +$660K 1.89% 7
2018
Q1
$1.59M Buy
+50,568
New +$1.62M 1.34% 6

Other funds holding SPDW

Sanctuary Wealth Management's SPDW Position: Q4 2024 in Review

Sanctuary Wealth Management held its State Street SPDR Portfolio Developed World ex-US ETF (SPDW) position steady in Q4 2024 at 4,460 shares worth $152K. The position accounts for 0.1% of the portfolio, ranked #50.

Sanctuary Wealth Management first reported a position in SPDW in Q1 2018 and has held it in 10 quarters since. The position peaked at $2.17M in Q2 2018. 968 funds tracked by Wall St. Rank hold SPDW as of Q4 2024.

  • Sanctuary Wealth Management held 4,460 shares of State Street SPDR Portfolio Developed World ex-US ETF worth $152K as of Q4 2024.
  • Sanctuary Wealth Management left its State Street SPDR Portfolio Developed World ex-US ETF share count unchanged in Q4 2024.
  • State Street SPDR Portfolio Developed World ex-US ETF made up 0.1% of Sanctuary Wealth Management's portfolio in Q4 2024, its #50 holding.
  • Sanctuary Wealth Management first reported a position in State Street SPDR Portfolio Developed World ex-US ETF in Q1 2018 and has held it in 10 quarters since.
  • Sanctuary Wealth Management's State Street SPDR Portfolio Developed World ex-US ETF position peaked at $2.17M in Q2 2018.
  • 968 funds tracked by Wall St. Rank held State Street SPDR Portfolio Developed World ex-US ETF as of Q4 2024.

Based on Sanctuary Wealth Management's 13F filing for Q4 2024, filed 12 Feb 2025.